Phase 1/1B trial of the heat shock protein 90 inhibitor NVP-AUY922 as monotherapy or in combination with bortezomib in patients with relapsed or refractory multiple myeloma

Ruth Seggewiss-Bernhardt, Ralf C. Bargou, Yeow Tee Goh, A. Keith Stewart, Andrew Spencer, Adrian Alegre, Joan Bladé, Oliver G. Ottmann, Cristina Fernandez-Ibarra, Hong Lu, Scott Pain, Mikhail Akimov, Swaminathan Padmanabhan Iyer

Research output: Contribution to journal › Article › peer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 1/1B trial of the heat shock protein 90 inhibitor NVP-AUY922 as monotherapy or in combination with bortezomib in patients with relapsed or refractory multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences